Terry Gernsheimer is a Hematology physician affiliated with University of Washington. OpenAlex indexes 148 publications with 15,453 citations (h-index 44); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Seattle Cancer Care Alliance
825 Eastlake Avenue East
Seattle, WA 98109
Telephone
206-288-1012Registry record last updated 31 Mar 2009.
Clinical trials
- Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Sponsor: Cellphire Therapeutics, Inc.
- American Trial Using Tranexamic Acid in Thrombocytopenia
Sponsor: University of Washington
- Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
Sponsor: U.S. Army Medical Research and Development Command
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20256 payments
- SOBI, INCProgram year20245 payments$17,644openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year20244 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2015–2019 per NIH RePORTER. The latest:
- American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
University of Washington
FY2019$885,149U01HL122894 - American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
University of Washington
FY2018$1,190,601U01HL122894 - American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
University of Washington
FY2017$1,502,614U01HL122894
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
Therapeutic Advances in Hematology
2023 - Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination
American Journal of Hematology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Rainer Storb
University of Washington
Connie Celum, MD, MPH
University of Washington
Helen Chu, MD, MPH
University of Washington
Bryan Kestenbaum, MD
University of Washington
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”